In addition, to examine whether our findings would translate to humans we also examined the relationship between hepatic PNPLA3 expression and hepatic triglyceride and diacylglycerol (DAG) content in liver biopsies that were obtained from obese patients with NAFLD undergoing gastric bypass surgery. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.